| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | 10%+ Owner | Common Stock | 4.44M | $58.8M | $13.24 | Sep 16, 2024 | By Biocon Limited |
| Bicara Therapeutics Inc. | 10%+ Owner | Common Stock | 1.08M | $14.3M | $13.24 | Sep 16, 2024 | By Biocon Pharma Inc. |
| Bicara Therapeutics Inc. | 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | Sep 16, 2024 | By Biocon Limited | ||
| Bicara Therapeutics Inc. | 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | Sep 16, 2024 | By Biocon Pharma Inc. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | Sep 16, 2024 | 4 | $0 | 4 | Sep 16, 2024 | 10%+ Owner |
| BCAX | Bicara Therapeutics Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | 10%+ Owner |